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There is a large body of emerging literature suggesting that physical activity is regulated to a varying extent by 
biological factors. Available animal data strongly suggests that there is a differential regulation of physical activ-
ity by sex and that the majority of this differential regulation is mediated by estrogen/testosterone pathways 
with females in many animal species having higher daily activity levels than males. The purpose of this manu-
script is to review the mechanisms by which estrogen, progesterone, and testosterone affect the regulation of 
physical daily activity. This review lays the foundation for future investigations in humans as well as discus-
sions about relative disease risk mediated by differential biological regulation of physical activity by sex. 
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I. Introduction 
 The use of animal models as proctors for human 
physiology has a long and significant history. Subse-
quently, some researchers have turned to using animal 
models to increase understanding of the mechanistic 
underpinnings of exercise behaviors. This work is 
critical given the literature that indicates a general de-
cline in physical activity [50] and an increase in obe-
sity and other hypokinetic diseases in most West-
ern-cultures [27]. While physical activity has normally 
been considered a ‘voluntary activity’, held to 
free-will and influenced solely by environmental fac-
tors there is a growing body of literature that suggests 
that physical activity is significantly regulated by bio-
logical factors. These biological regulating factors may 
take many forms including a central nervous cen-
ter-located “activity-stat” [38], an increase or decrease 
in various physiological substance or structures (e.g. 
GLUT4 ref. [51]), and/or genetics [23, 25, 46]. Biologi-
cally, the sex hormones play a large role in regulating 
various physiological parameters in both males and 
females and thus would be the natural subject of in-
vestigations into possible roles they play in regulating 
physical activity. Therefore, the focus of this paper is 
to review the literature investigating the effect of and 
the physiological mechanisms through which estro-
gen, progesterone, and testosterone may regulate 
physical activity. Given the sparseness of the human 
literature in this area, the primary model used in this 
research has been animal models. 
II. Sex differences in physical activity  
In general, it is commonly accepted that human 
females are less active than males; this sex differentia-
tion in activity is prevalent in both children and ado-
lescents [31] as well as adults [50]. However, con-
founding factors in human research in this area, in-
cluding the well-known difficulty of accurately meas-
uring physical activity in large populations [42], the 
complexity of giving hormone treatments in a physio-
logically-relevant and ethical manner [52], the general 
lack of well-controlled prospective human studies in 
this area, and the near impossibility of controlling en-
vironmental variations that can influence activity lev-
els make understanding human sex differences in ac-
tivity extremely problematic. Given these difficulties 
and the relative ease of experimental control in animal 
studies, it is appropriate to consider whether there is a 
sex difference in activity present in animal models. 
The rodent literature that addresses sex hormone 
effects on activity generally shows that female rodents 
are more active than male rodents. Figure 1 is a sum-
mary of representative literature that has observed sex 
differences in daily activity in rats or mice. Overall, 
female rodent activity levels on a daily basis range 
from 20% to over 50% higher than males. Bronstein, et 
al. [6] observed that female Sprague-Dawley rats trav-
ersed significantly more distance during open-field 
testing (ranging from 28-46% more) than male rats, 
regardless of whether the animals had been handled 
or not. Craft, et al. [8] while considering sex differ-
ences in morphine-induced locomotor changes, ob-
served that in the baseline state, female Spra-
gue-Dawley rats exhibited 46% - 72% more activity (as 
measured by photobeam breaks in their home cage) 
than males over a 3-5 hour period, depending upon Int. J. Biol. Sci. 2008, 4 
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whether they had been handled or not. Li, et al. [24] 
showed that there may be strain differences in these 
sex-related patterns of activity by showing that while 
the total path length that Wistar and WKY rats ran 
were significantly higher in females, there were no 
observed differences between sexes in the SHR rats. 
An earlier strain screen study in mice [25] showed that 
while overall female mice ran approximately 20% 
further per day than male mice, there was large vari-
ability in this percentage depending upon which of 
the 13 strains were tested. The percentage difference 
between female and male mice of the same strain in 
distance run on a daily basis ranged from -21.9% 
(SPRET/EiJ) to 111.2% (C3H/HeJ). Similar variation 
was also observed in duration and speed phenotypes. 
This type of between strain variation in photobeam 
break activity data has also been observed by Seburn 
within the Mouse Phenome database [41]. Earlier 
work by Koteja, et al. [21] monitored wheel running 
activity in both control Hsd:ICR mice and mice from 
generation 10 of an ongoing study to selectively breed 
mice for wheel-running activity. While there were sig-
nificant differences between the control and selected 
lines in daily wheel-running activity, there were also 
significant sex-differences in the amount of distance 
run reported in both the control lines (50% higher in 
females) and the selected lines (58% higher in fe-
males). Recent work from our laboratory [26] with a 
large cohort of F2 animals (n=310) developed from 
reciprocally breeding high active C57L/J and low ac-
tive C3H/HeJ inbred mouse strains have shown that 
on average (over 21 days), the female animals ran 47% 
farther, 39% longer, and 9% faster than male animals. 
 
Figure 1 – Representative literature reporting percentage dif-
ference in female activity vs. male activity in rodents. 
 
In summary, the majority of the animal literature 
over the past 80 years, have largely accepted that 
physical activity can be governed by biological factors 
and thus, activity levels are routinely treated as the 
dependent variable in many study designs. Addition-
ally, given that most environmental factors can be 
controlled when using animal models, the animal lit-
erature has appropriately focused upon the role that 
sex hormones play in regulating daily activity, as 
Gorzek, et al. [15] did in investigating the effect of es-
trogen on daily activity levels.   
III. Effects of sex hormones on activity in ani-
mal models 
  The investigation of the effect of sex hormones 
on physical activity in rodent models has a long and 
varied history. Figure 2 (R. Bowen personal commu-
nication) shows the interesting waxing and waning of 
such research over the past 80 years. While a complete 
historical review of this topic is outside the scope of 
this paper, it is of note that the consideration of sex 
hormone effects on activity was initiated in the early 
1920’s when it was found that ovariectomies signifi-
cantly decreased activity in female rats in conjunction 
with the observation of a marked decrease in 
wheel-running activity in male rats after castration 
[18, 35, 44]. These studies also noted that implantation 
of ovarian tissue into both female rats [35, 44] and 
male rats [54] ‘recovered’ the pre-neutering activity 
patterns whereas implantation of testes into both male 
and female rats increased activity to a lesser extent 
than the ovarian implants [36]. The evidence from 
these studies, produced before estrogen, progesterone, 
or testosterone were isolated and identified, were so 
strong that one researcher concluded that in female 
rats, “Obviously, therefore, the spontaneous activity is 
dependent on ovarian function”. However, this same 
researcher cautioned that none of the available ex-
periments proved that the “hormone actually produces 
activity” (their emphasis) [35].   
 
Figure 2 – The yearly distribution of studies regarding the effect 
of sex hormones on physical activity. The x-axis designates the 
ten-year period in which the studies were published. (Personal 
communication from R. Bowen) Int. J. Biol. Sci. 2008, 4 
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Several studies since these early findings have 
shown that estrogen and testosterone directly impact 
spontaneous activity in rodent models. For example, 
recently Gorzek and colleagues [15] showed that while 
ovariectomies reduced daily wheel-running activity in 
female mice, a dosage of 3 µg•d-1 of 17β-estradiol in-
creased activity to a level comparable to activity in 
sham-operated mice. Roy and Wade [39] demon-
strated that administration of varying doses of testos-
terone propionate (100µg-1mg/day) increased run-
ning wheel activity in castrated male rats. These two 
studies, which are two examples of numerous studies, 
provide evidence of a cause/effect relationship be-
tween reproductive hormones and spontaneous activ-
ity in rats and mice. 
Estrogen 
While several studies have observed a causal re-
lationship between the sex hormones, particularly es-
trogen, and spontaneous activity, the mechanistic un-
derpinnings of this relationship has been somewhat 
unclear. Cushing, in a series of experiments (summa-
rized by ref. [9]), investigated the role of sexual recep-
tivity on the relationship between estrogen and activ-
ity using prairie voles. Female prairie voles, unlike 
other female rodents, are unique in that they undergo 
induced estrus by exposure to male voles and their 
sexual receptivity does not require progesterone, thus, 
removing two possible confounding factors that might 
influence activity. Cushing and Hite [9] found that 
sexually mature virgin female voles did not increase 
seven-day wheel running behavior either with or 
without estradiol injections (0.05µg or 0.5µg estradiol). 
It had been earlier shown that the number of estradiol 
receptors in the brain had previously been shown to 
increase in female voles when exposed to males [7]. 
Thus, the observation of a the lack of an increase in 
spontaneous activity with estradiol administration 
before exposure to males suggested that estradiol’s 
effect on spontaneous activity was linked to the in-
creased number of estradiol receptors in the brain.   
Most research investigating the mechanisms of 
estrogenic increases in activity have focused on central 
neural pathways [12, 13, 30]. Bilateral implantation of 
estradiol in the medial preoptic area and the anterior 
hypothalamus was shown to variably increase wheel 
running activity in ovariectomized female rats [12]. 
Since the preoptic area contains both estrogen receptor 
isoforms - alpha (ERα) and beta (ERβ) – while the hy-
pothalamic areas contain primarily ERα and little if 
any ERβ [43], Fahrbach, et al. [12] suggested that 
ERα may control the estrogenergic effect on activity. 
This hypothesis was difficult to test since 17β-estradiol 
has a similar affinity for both ERα and ERβ receptor 
subtypes [22].   
Coumesterol is a phytoestrogen with similar af-
finity as 17β-estradiol for ERβ, but four-fold less affin-
ity for ERα and seven-fold higher affinity for ERβ than 
for ERα [22]. Garey and colleagues [13] injected 
coumestrol (10 µg), singly and in combination with 
estradiol implants (2.5µg) in 48 adult, ovariectomized 
Swiss-Webster mice and measured running wheel ac-
tivity for the following 10 days. Running wheel activ-
ity increased with estradiol administration (Fig. 3), but 
coumestrol administration did not alter running wheel 
behavior as compared to a placebo injection. From this 
data, the authors suggested that the ERβ-pathway did 
not influence spontaneous activity; rather, the in-
creases in spontaneous activity arising from estrogen 
administration were mediated primarily through the 
ERα pathway. Additionally, Garey, et al.’s data also 
eased concerns that the phytoestrogens in the stan-
dard rodent chows that have been used in many of the 
published rodent activity papers (e.g. [20, 21, 23, 25, 
47, 48, 53]) have not confounded the conclusions of 
these studies as has been noted for other areas of ro-
dent physiology (e.g. [45]). 
 
Figure 3 – Wheel running behavior after five days of phytoes-
trogen supplementation. *Significantly different from vehi-
cle/placebo treatment. Drawn from tabular data presented by 
Garey, et al. [13]. 
 
Garey and colleagues’ [13] suggestion that the 
estrogen-induced increases in spontaneous activity are 
mediated through the ERα pathway has been sup-
ported by further experiments with knock-out ani-
mals. Ogawa, et al. [30], using gonadectomized 
knock-out mice that lacked either ERα or ERβ genes, 
implanted either a 17β-estradiol capsule (16 or 160 
ng/d) or a placebo capsule and monitored running 
wheel activity for nine days. Ogawa and colleagues 
observed that both male and female wild-type mice 
(i.e. with ERα and ERβ pathways intact) increased Int. J. Biol. Sci. 2008, 4 
 
129
running wheel activity significantly with either 16 or 
160 ng/d estradiol treatments as compared to placebo 
mice. Additionally, with estradiol treatments, both 
sexes of the ERβ knock-out mice also significantly in-
creased their running wheel activity compared to pla-
cebo; however, even with estradiol administration, the 
ERα knock-out mice did not increase activity com-
pared to placebo. These results, in conjunction with 
Garey, et al.’s earlier study on coumesterol [13] lend 
strong evidence to the hypothesis that the estrogenic 
effects on running wheel behavior in mice are medi-
ated through the ERα-pathway. 
While it appears that estrogenic activation of the 
ERα-pathway is the primary mediator of the increase 
in running wheel behavior, the mechanisms through 
which the ERα-pathway influences activity are un-
clear. Morgan, et al. [28] have speculated that the 
ERα-pathway modulates several neurotransmitters, 
including dopamine and/or serotonin, which may 
play a role in the regulation of activity. In a review of 
the interactions of the sex differences in dopaminergic 
r e g u l a t i o n ,  B e c k e r  [ 3 ]  p r o p o s e d  t h a t  i n  f e m a l e  r a t s ,  
estrogen enhanced terminal release of dopamine rela-
tive to male rats, which explains, the authors note, 
many reproductive-related behaviors such as in-
creased pacing behavior. Additionally, it has been ob-
served that estrogen can regulate several different 
steps in dopaminergic functioning, including dopa-
mine release and metabolism as well as the pre- and 
post-synaptic receptor and transporter functioning 
(for review see [10]). Interestingly, effects of estrogen 
on dopamine receptors and transporter mechanisms 
in the nucleus accumbens have been noted to be as 
fast as two minutes; faster than would be expected 
from genomic activation [49] suggesting an influence 
of estrogen on the dopaminergic systems not arising 
through activation of either the ERα or ERβ pathways. 
Supporting this nongenomic activation hypothesis are 
observations of nongenomic effects of estrogens pos-
tulated to occur through the activation of a common 
membrane binding site with the same pharmacologi-
cal profile as the hypothesized γ-adrenergic receptor 
[29]. 
Whether a differential activation of the dopa-
minergic systems by the ERα pathway or some other 
nongenomic pathway leads to the sex-related differ-
ence in activity levels is currently unknown. However, 
the involvement of dopamine in regulating daily ac-
tivity is supported by indirect evidence. Garland’s 
group [33, 34] have suggested that an alteration in 
dopaminergic functioning is one of the primary char-
acteristics of mice experimentally evolved for high 
activity. Specifically, Rhodes and Garland have ob-
served that an inhibition of dopamine transporter 
(DAT) will reduce the wheel-running of mice that are 
high active [34]. Additionally, they have shown that 
female high active mice have a reduced functioning of 
the D1 and D5 dopamine receptors [33]. Whereas 
Rhodes and Garland only studied female mice in each 
of their studies, it is yet to be determined if these al-
terations in dopaminergic functioning are different in 
male high active mice. Thus, while tenuous evidence 
suggests that the estrogen activation of the 
ERα-pathway and a possible nongenomic pathway 
may lead to an enhanced release of dopamine in fe-
male rodents which coupled with alterations in do-
pamine transport and/or receptors, may lead to in-
creased activity, it is unclear whether this results in 
differential levels of activity between sexes.   
Progesterone 
While there have been numerous investigations 
of estrogen’s role in determining physical activity lev-
els in animal models, there have been virtually no 
studies considering whether progesterone influences 
activity. Progesterone is known to impact several 
physiological mechanisms and given that estrogen 
and progesterone normally cycle together during at 
least one portion of the female reproductive cycle [16], 
progesterone could also affect activity behavior. In a 
larger study concentrating on the differential effect of 
estradiol and estrone on activity, Young and Fish [55] 
noted that progesterone injected in conjunction with 
estradiol did not influence activity in rats in any 
manner. This result was expanded upon in a 
three-phase study conducted by Rodier [37] which is 
the only other currently available study in this area. 
Sherman albino rats received varying dosages of pro-
gesterone (4, 8, or 40 mg/kg/day) or placebo injec-
tions. Rodier noted that injections of 8 or 40 
mg/kg/day in gonadally-intact rats decreased normal 
wheel-running activity, but neither an injection of 4 
mg/kg/day progesterone or placebo solvents 
changed normal activity levels. Rodier then ovariec-
tomized seven of the rats, injected them with 40 
mg/kg/day progesterone for six days and then in-
jected them with solvent for another six days. After 
ovariectomy, activity decreased to a level similar to 
that seen with progesterone injection in intact animals 
and was not further depressed with subsequent pro-
gesterone injection suggesting that progesterone was 
interfering with endogenous estrogens’ effects on 
physical activity. To determine if exogenous estrogen 
interacted with the progesterone inhibition of 
wheel-running activity, Rodier then injected 
17β-estradiol (100 µg/kg) into the ovarectomized and 
control animals, with each injection separated by five 
days. Eight days after the last estradiol injection, he 
injected either progesterone (40 mg/kg/day) or a pla-Int. J. Biol. Sci. 2008, 4 
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cebo. While the estrogen injections increased the ani-
mals’ running wheel behavior for at least 21 days after 
the first injection, the animals receiving the proges-
terone injections sharply decreased their activity, 
which then increased again after the cessation of the 
progesterone injections. Thus, given that either intrin-
sic or extrinsic estrogen had to be present for the in-
hibitory effects of progesterone to be observed, Rodier 
suggested that the progesterone decrease in physical 
activity was mediated through a direct interference 
with estrogen. A negative interference of progesterone 
on estrogenergic effects on neurotransmitters has been 
observed in both rats [17] and primates [14]; con-
versely, there is also literature available suggesting 
that progesterone augments [4] or has no effect [2] on 
estrogenic effects on neurotransmitters. However, an 
interference of progesterone on estrogen’s physical 
activity effects is attractive to hypothesize because 
such an interference would explain the common sinu-
soidal activity pattern observed in female rats [35]; it 
could be suggested that peak activity was occurring 
during the follicular phase due to the primacy of the 
estrogen peak with the subsequent decrease in physi-
cal activity occurring during the luteal phase when 
progesterone is the dominant hormone and is inter-
fering with estrogen’s activity increasing effects. The 
dearth of investigations in this area leaves this and 
other hypotheses related to progesterone and estro-
gen’s interactions on activity, such as the role of 
physiological doses of progesterone in activity regula-
tion and the specific site(s) and mechanism(s) of the 
estrogen/progesterone interference open for further 
investigation. 
Testosterone 
In rodents, several studies using orchidec-
tomized males have indicated a potential role for sex 
hormones in the regulation of activity [5, 36, 39]. For 
example, Broida and Svare [5] showed that locomotor 
activity – measured by photobeam breaks - could be 
rescued in castrated animals by implanting silastic 
capsules containing testosterone. Additionally, Broida 
and Svare suggested that there may be a genotype 
dependency in these responses, since they observed a 
larger decrement in physical activity after castration in 
inbred C57BL/6J mice as compared to inbred DBA/2J 
and random-bred Rockland-Swiss mice [5].   
While a possible role for testosterone in the 
regulation of daily activity has been proposed [5, 36, 
39], few studies have attempted to determine mecha-
nistic causes of this effect. Roy and Wade [39] in a 
widely quoted study, injected either testosterone (100 
µg/day), estradiol (10 µg/day), dihydrotestosterone 
propionate (DHTP - 100 µg/day), or sesame oil (pla-
cebo) into 20 castrated adult male Sprague-Dawley 
rats and then monitored running wheel activity for 16 
days. They noted that testosterone injections signifi-
cantly increased the running wheel activity of the rats 
(p<0.05) but not as much as estradiol injections 
(p<0.02). Neither the DHTP or placebo injections in-
creased running activity above baseline. Given that 
testosterone is aromatizable to estrogen whereas 
DHTP is not, the authors concluded that the primary 
mechanism regulating running wheel activity with 
testosterone administration was the aromatization of 
the testosterone into estrogen. In the second part of 
this experiment [39], these authors found that admini-
stration of an estrogen antagonist (MER-25) attenu-
ated the increased running wheel activity resulting 
from either estradiol or testosterone injection. These 
results further supported the hypothesis that the in-
creased activity from testosterone injection was medi-
ated by the estrogen pathways. 
While it appears that testosterone injec-
tions/implants can rescue activity levels after or-
chidectomy, supplementation of testosterone in intact 
animals does not increase physical activity levels. 
Eleftheriou and colleagues observed that testosterone 
level was not significantly correlated to a single 24 
hour observation of wheel-running activity [11] in 
gonadally intact male C57BL/6By and Balb/cBy mice, 
in seven recombinent inbred strains (CXBD, CXBE, 
CXBG, CXBH, CXBI, CXBJ, and CXBK) or in two F1 
hybrid strains (B6CF1 and CB6F1). Salvador, et al. [40] 
showed that suprapharmacological doses (3.75, 7.5, 15, 
or 30 mg/kg) of artificial anabolic-androgenic steroids 
(testosterone propionate and nandrolone decanoate), 
injected into gonadally intact male OF1 male mice, did 
not affect running wheel activity measured 24 hours 
after the injection. Furthermore, mice injected with 
suprapharmacological doses for 10 weeks, did not 
show alterations in activity levels compared to base-
line during 24 hour monitoring periods in the eight, 
ninth, or tenth week. These results support work in 
rats by Li and Huang [24] that showed that testoster-
one injections in both male and female go-
nadally-intact animals did not generally result in an 
increase in total path length. Thus, while work in go-
nadally-deficient animals has shown that testosterone, 
after aromatization to estrogen, will increase physical 
activity levels in rodents, supplementation above 
baseline levels will not further increase activity.   
V. Summary 
A wide-variety of evidence suggests that in ro-
dents, females are generally more active than males, 
with a large proportion of this differential activity ex-
plained by sex hormone effects. The mechanism of this 
regulation (Fig. 4) appears to be mediated through the Int. J. Biol. Sci. 2008, 4 
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estrogen-α receptor pathway with the requirement of 
aromatization of testosterone to estrogen in males. 
Little literature exists to explain the mechanism lead-
ing from estrogen-α receptor activation to an increase 
in activity; however, recent literature has suggested 
that alterations in dopaminergic systems as well as 
possible non-genomic actions of estrogen may be in-
volved. The few available human studies in this area 
[1, 19, 32] have contained multiple confounders that 
make deriving any useful conclusions from these 
studies difficult at best. Thus, extensions of the exist-
ing mechanistic studies on ERα-pathway regulation of 
physical activity in rodents as well as more carefully 
controlled human studies are needed to determine if 
sex hormones provide any physiological regulation of 
activity in humans and if so, possible pathways 
through which this effect may be mediated. The in-
creasing rate of inactivity which has led to the in-
creased cardiovascular and other hypokinetic diseases 
in most populations [27] make understanding the 
mechanisms of physical activity regulation critical in 
the context of the health-related goals of our society.   
 
Figure 4 – Hypothesized schematic of the regulation of physi-
cal activity by sex hormones in rodents. “?” = pathway cur-
rently supported by speculation and/or tentative data. DAT = 
dopamine transporter; D2/D4, D1/D5 signify different dopa-
mine receptor populations. 
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